Consistent with our findings, Avery et al. demonstrated that the rs4420638A/G polymorphism of the apoC1 gene was associated with elevated plasma glucose, atherogenic dyslipidemia, vascular inflammation, and central obesity in individuals of European descent [34]. This evidence concerns the gene APOC1 and metabolic syndrome.